Item 5. OTHER INFORMATION

On May 21, 2024, Cristiano Amon, our President and Chief Executive Officer, acting as trustee on behalf of his family trust, adopted a Rule 10b5-1 trading arrangement (as defined in Item 408 of Regulation S-K) providing for the sale of up to 75,000 shares of our common stock. The plan is scheduled to terminate on September 30, 2025.

On June 6, 2024, Ann Chaplin, our General Counsel and Corporate Secretary, adopted a Rule 10b5-1 trading arrangement providing for the sale of (i) 50% of the net shares issued to Ms. Chaplin upon the vesting of restricted stock unit awards representing 25,216 shares of our common stock and (ii) 60% of the net shares issued to Ms. Chaplin upon the vesting of performance stock unit awards representing 45,074 shares of our common stock (assuming that such shares underlying performance stock units vest at target amounts), including, in each case, accrued dividend-equivalent shares and excluding any shares withheld to satisfy tax withholding obligations in connection with the settlement of such awards. The plan is scheduled to terminate on December 31, 2025.

On June 6, 2024, Neil Martin, our Senior Vice President, Finance and Chief Accounting Officer, adopted a Rule 10b5-1 trading arrangement providing for the sale of the net shares issued to Mr. Martin upon the vesting of restricted stock unit awards representing 9,030 shares of our common stock, including accrued dividend-equivalent shares and excluding any shares withheld to satisfy tax withholding obligations in connection with the settlement of such awards. The plan is scheduled to terminate on June 5, 2026.